Sweating is a physiological process, which is vital for maintaining a constant body temperature and good grip function. Excessive sweating (hyperhidrosis) can on the contrary lead to severe social problems for the affected individual with a decreased quality of life (1). Primary or essential hyperhidrosis is seen symmetrically located to palms, feet, axillae and groins/anogential or generalised...

Muscle cramps may be caused by fluid and salt loss induced by diffuse or focal hyperhidrosis. Recent reports have described the efficacy of botulinum, toxin in the treatment of primary focal hyperhidrosis. Botulinum toxin inhibits sweating by blocking exocytosis of acetylcholine from presynaptic cholinergic nerve terminals. We report the case of a patient who complained of frequent muscle cramp...

BACKGROUND Primary hyperhidrosis (PH) can lead to mood changes due to the inconveniences it causes. OBJECTIVE This study aimed to examine the existence of anxiety and depression in patients with severe primary hyperhidrosis who sought treatment at a medical office. METHODS The questionnaire "Hospital Anxiety and Depression Scale" was used for 197 individuals, in addition to the chi square t...

BACKGROUND Hyperhidrosis (primary or secondary) is excessive sweating beyond that required to return body temperature to normal. It can be localized or generalized, commonly affecting the axillae, palms, soles or face, and can have a substantial negative effect on a patient's quality of life. IMPACT OF DISEASE Objective evaluation comprising quantitative assessment (gravimetric and Minor's io...

Background: Primary focal hyperhidrosis can significantly reduce quality of life. Therefore a lot of treatment options in a range of conservative, physical and surgical techniques are available. Objective: To assess the efficacy of an antiperspirant containing aluminum chloride compared to a Botulinumtoxin A treatment for patients with primary focal hyperhidrosis. Methods and material: In this ...

dermatitis or bacterial and mycological infections (1). BTXA has been used recently to treat focal hyperhidrosis (gustatory sweating, palmo-plantar and axillary hyperhidrosis) (4, 5). There are no data available for the treatment of stump hyperhidrosis. We used BTXA for stump hyperhidrosis in a dosage comparable to that used in palmar hyperhidrosis, i.e. 100 U of Botox. The treatment was very e...

BACKGROUND Hyperhidrosis affects approximately 3% of the population. The nature of those patients presenting for treatment has not been well studied, however. OBJECTIVE The objective was to perform a descriptive, multicenter study of patterns of patients referred for treatment of focal hyperhidrosis. METHODS AND MATERIALS A convenience sampling of consecutive patients referred for considera...